Cochrane Abstracts
Esketamine for treatment‐resistant depression in adults
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Esketamine for Treatment‐resistant Depression in Adults." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439347/all/Esketamine_for_treatment‐resistant_depression_in_adults.
Esketamine for treatment‐resistant depression in adults. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439347/all/Esketamine_for_treatment‐resistant_depression_in_adults. Accessed March 21, 2025.
Esketamine for treatment‐resistant depression in adults. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439347/all/Esketamine_for_treatment‐resistant_depression_in_adults
Esketamine for Treatment‐resistant Depression in Adults [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439347/all/Esketamine_for_treatment‐resistant_depression_in_adults.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Esketamine for treatment‐resistant depression in adults
ID - 439347
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439347/all/Esketamine_for_treatment‐resistant_depression_in_adults
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
